Replicate Bioscience, Inc.

Replicate Bioscience, Inc. is at the forefront of biotechnology, dedicated to amplifying the power of RNA therapeutics through its innovative self-replicating RNA (srRNA) technology. Replicate Bioscience's off-the-shelf srRNAs are composed of two key elements: virally derived genetic code that facilitates controlled and self-limiting amplification, and RNA encoding therapeutic proteins. This cutting-edge approach positions Replicate Bioscience as a leader in the next generation of RNA-based treatments.

With a comprehensive library of viral vectors, carefully selected to drive robust and sustained protein expression, Replicate Bioscience is significantly improving performance compared to traditional linear mRNA. This allows for the development of groundbreaking treatments across a range of therapeutic areas, including oncology, infectious diseases, and autoimmunity. Replicate Bioscience is committed to expanding the reach of RNA treatments, making them more accessible and effective for patients worldwide.

Located at 10210 Campus Point Dr, #150, San Diego, California 92121, US, Replicate Bioscience is driven by a team of srRNA experts and offers a customizable library of synthetic srRNA vectors alongside end-to-end development capabilities. This unique combination empowers Replicate Bioscience to pioneer widespread use of RNA treatments in immuno-oncology, autoimmune diseases, and beyond. We invite the management team at Replicate Bioscience, Inc. to create a customized and exclusive company showcase and product listing on our platform.